Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109


NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway.

Guan H, Moretto M, Bzik DJ, Gigley J, Khan IA.

J Immunol. 2007 Jul 1;179(1):590-6.


NK cells promote type 1 T cell immunity through modulating the function of dendritic cells during intracellular bacterial infection.

Jiao L, Gao X, Joyee AG, Zhao L, Qiu H, Yang M, Fan Y, Wang S, Yang X.

J Immunol. 2011 Jul 1;187(1):401-11. doi: 10.4049/jimmunol.1002519. Epub 2011 Jun 3.


IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.

Terme M, Tomasello E, Maruyama K, Crépineau F, Chaput N, Flament C, Marolleau JP, Angevin E, Wagner EF, Salomon B, Lemonnier FA, Wakasugi H, Colonna M, Vivier E, Zitvogel L.

J Immunol. 2004 May 15;172(10):5957-66.


Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A.

J Immunol. 2002 Jun 15;168(12):5997-6001.


Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.

Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.

J Immunol. 2005 Jul 15;175(2):720-9.


Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N.

J Immunol. 2004 Nov 15;173(10):6072-81.


Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA, Storkus WJ, Kalinski P.

J Immunol. 2003 Sep 1;171(5):2366-73.


NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.

Combe CL, Curiel TJ, Moretto MM, Khan IA.

Infect Immun. 2005 Aug;73(8):4913-21.


Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM.

J Immunol. 2003 Dec 15;171(12):6891-9.


A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.

Zhou H, Luo Y, Kaplan CD, Krüger JA, Lee SH, Xiang R, Reisfeld RA.

Blood. 2006 Apr 15;107(8):3251-7. Epub 2005 Dec 20.


Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens.

Berberich C, Ramírez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H.

J Immunol. 2003 Mar 15;170(6):3171-9.


Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.

Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC, López-Albaitero A, Gibson SP, Gooding WE, Ferrone S, Ferris RL.

Clin Cancer Res. 2013 Apr 1;19(7):1858-72. doi: 10.1158/1078-0432.CCR-12-2426. Epub 2013 Feb 26.


Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells.

Persson CM, Lambert H, Vutova PP, Dellacasa-Lindberg I, Nederby J, Yagita H, Ljunggren HG, Grandien A, Barragan A, Chambers BJ.

Infect Immun. 2009 Mar;77(3):970-6. doi: 10.1128/IAI.00833-08. Epub 2009 Jan 12. Erratum in: Infect Immun. 2009 Aug;77(8):3516.


EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity.

Galazka G, Jurewicz A, Orlowski W, Stasiolek M, Brosnan CF, Raine CS, Selmaj K.

J Immunol. 2007 Oct 1;179(7):4503-12.


Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection.

Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, Suzuki T, Miyagi T, Hayashi N.

J Immunol. 2003 Nov 15;171(10):5423-9.


Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB.

Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. Review.


Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities.

Jinushi M, Takehara T, Tatsumi T, Yamaguchi S, Sakamori R, Hiramatsu N, Kanto T, Ohkawa K, Hayashi N.

Immunology. 2007 Jan;120(1):73-82. Epub 2006 Oct 18.


NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P.

J Immunol. 2007 Mar 1;178(5):2688-98.

Supplemental Content

Support Center